USPatentGranted
B2

Genetically modified mice that produce hybrid antibodies

Granted 25 Nov 2014 · 8 office actions

Life of the patent

3 dated events
⤢ drag to zoomOct 2013Jan 2014Apr 2014Jul 2014Oct 2014Jan 2015Prosecution
Prosecutionhover for detail · click to open

Abstract

A method for engineering and utilizing large DNA vectors to target, via homologous recombination, and modify, in any desirable fashion, endogenous genes and chromosomal loci in eukaryotic cells. These large DNA targeting vectors for eukaryotic cells, termed LTVECs, are derived from fragments of cloned genomic DNA larger than those typically used by other approaches intended to perform homologous targeting in eukaryotic cells. Also provided is a rapid and convenient method of detecting eukaryotic cells in which the LTVEC has correctly targeted and modified the desired endogenous gene(s) or chromosomal locus (loci) as well as the use of these cells to generate organisms bearing the genetic modification.

Claims

5 · 2 independent · depth 2
12345
5 granted claims

Classifications

13 codes
IPC · International Patent Classification
Section A — Human necessities
  • A01K67/027
Section C — Chemistry; metallurgy
  • C12N15/85
  • C07K16/46
  • C07K16/00
  • C12N15/63
  • C12N15/90
  • C12N15/67
  • C07K16/28
  • C12P21/00
USPC · US Patent Classification
800/18800/6800/8800/21

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this patent are not paired with the granted ones in what we hold.

File wrapper

Pendency
1.1 y
417 days filing → grant
Office actions
4
non-final + final
Responses
8
1 RCE
Interviews
2
examiner interview summaries
Examiner
Anoop Singh
art unit 1632 · TC 1600
Citations: 421 back · 0 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Term & fees

See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.

Log in to unlock

Priority chain

1 priority documents
›Priority documents — 1
TypeDocumentDate
related publicationUS 20140033337 A130 Jan 2014

Validity challenges

See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.

Log in to unlock

Citations

See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.

Log in to unlock